全文获取类型
收费全文 | 3395篇 |
免费 | 110篇 |
国内免费 | 110篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 235篇 |
妇产科学 | 34篇 |
基础医学 | 596篇 |
口腔科学 | 14篇 |
临床医学 | 249篇 |
内科学 | 984篇 |
皮肤病学 | 31篇 |
神经病学 | 334篇 |
特种医学 | 50篇 |
外科学 | 315篇 |
综合类 | 185篇 |
预防医学 | 161篇 |
眼科学 | 33篇 |
药学 | 156篇 |
中国医学 | 35篇 |
肿瘤学 | 183篇 |
出版年
2024年 | 7篇 |
2023年 | 33篇 |
2022年 | 102篇 |
2021年 | 105篇 |
2020年 | 119篇 |
2019年 | 100篇 |
2018年 | 104篇 |
2017年 | 83篇 |
2016年 | 102篇 |
2015年 | 77篇 |
2014年 | 170篇 |
2013年 | 250篇 |
2012年 | 114篇 |
2011年 | 122篇 |
2010年 | 93篇 |
2009年 | 143篇 |
2008年 | 195篇 |
2007年 | 145篇 |
2006年 | 150篇 |
2005年 | 128篇 |
2004年 | 128篇 |
2003年 | 103篇 |
2002年 | 88篇 |
2001年 | 80篇 |
2000年 | 90篇 |
1999年 | 69篇 |
1998年 | 63篇 |
1997年 | 64篇 |
1996年 | 60篇 |
1995年 | 46篇 |
1994年 | 48篇 |
1993年 | 46篇 |
1992年 | 59篇 |
1991年 | 52篇 |
1990年 | 27篇 |
1989年 | 31篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 16篇 |
1985年 | 26篇 |
1984年 | 30篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 12篇 |
1974年 | 4篇 |
1973年 | 3篇 |
排序方式: 共有3615条查询结果,搜索用时 15 毫秒
21.
Research into Alzheimer’s disease (AD) has been guided by the view that deposits of fibrillar amyloid-β peptide (Aβ) are neurotoxic and are largely responsible for the neurodegeneration that accompanies the disease. This ‘amyloid hypothesis’ has claimed support from a wide range of molecular, genetic and animal studies. We critically review these observations and highlight inconsistencies between the predictions of the amyloid hypothesis and the published data. We show that the data provide equal support for a ‘bioflocculant hypothesis’, which posits that Aβ is normally produced to bind neurotoxic solutes (such as metal ions), while the precipitation of Aβ into plaques may be an efficient means of presenting these toxins to phagocytes. We conclude that if the deposition of Aβ represents a physiological response to injury then therapeutic treatments aimed at reducing the availability of Aβ may hasten the disease process and associated cognitive decline in AD. 相似文献
22.
《Journal of clinical lipidology》2020,14(3):322-330.e5
- Download : Download high-res image (435KB)
- Download : Download full-size image
23.
Dominantly inherited tubular aggregate myopathy. 总被引:1,自引:0,他引:1
We report an unusual familial myopathy characterized morphologically by the presence of large tubular aggregates in all fibre types. Two patients, a father and daughter, presented with slowly progressive proximal weakness, limitation of eye movement, and Achilles tendon contractures. Serum creatine kinase was 5-10 times normal. Light microscopy revealed type I fibre predominance. Basophilic accumulations, which stained intensely with the NADH-TR reaction, were present in both fibre types. Electron microscopy revealed that these consisted of tightly packed parallel tubular arrays. These varied somewhat in their ultrastructural appearance and were classified accordingly as type I, II, and III tubular structures. The tubular aggregates appear to be derived from the sarcoplasmic reticulum. This report further supports the evidence of a distinct clinico-pathological entity of genetic origin. 相似文献
24.
Shigemura K Shirakawa T Okada H Tanaka K Kamidono S Arakawa S Gotoh A 《Clinical and experimental medicine》2005,4(4):196-201
Abstract Familial hypercholesterolaemia is a genetic disorder characterised by high low-density lipoprotein (LDL) cholesterol concentrations,
which frequently gives rise to premature coronary artery disease (CAD). The clinical expression of familial hypercholesterolaemia
is highly variable even in patients carrying the same LDL receptor gene mutation. This variability may be due to environmental
and other genetic factors. Apolipoprotein E (Apo-E) has been extensively studied for its effects on the phenotype of familial
hypercholesterolaemia. In this study we examined the influence of Apo-E genotype on lipid parameters and the incidence of
CAD in 93 Greek patients with familial hypercholesterolaemia. Apo-E E2, E3 and E4 allele frequencies were 0.06, 0.86 and 0.09
respectively. The levels of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, apolipoproteins A and B and
lipoprotein α did not differ significantly among carriers and non-carriers of the E4 allele. The prevalence of CAD and hypertension
did not differ either. Our results suggest that the E4 allele is not associated with lipid levels or with the prevalence of
CAD among familial hypercholesterolaemia patients of the Greek population.
*The two authors were equally involved in the work 相似文献
25.
G. Feussner M. Eichinger R. Ziegler 《Journal of molecular medicine (Berlin, Germany)》1992,70(11):1027-1035
Summary Nineteen adult patients with type III hyperlipoproteinemia (HLP) and homozygosity for apolipoprotein (apo) E2 were treated with the 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) reductase inhibitor simvastatin (20 or 40 mg per day) alone or in combination with the fibrate derivative gemfibrozil (450 mg per day) during a 30-week outpatient study. With the 20-mg dose (n = 19) the mean plasma cholesterol level decreased from 13.24±8.04 8.04 at baseline to 8.04±4.19 mmol/l (mean reduction 39.3%; P<0.05), and the mean plasma triglyceride level decreased from 13.47±19.22 to 7.84±7.71 mmol/l (–41.8%; NS); this was due to a decrease in very low density lipoprotein (VLDL) cholesterol from 8.95±8.64 to 4.94±4.24mmo1/l (–44.8%; NS), a decrease in low density lipoprotein (LDL) cholesterol from 3.54±0.93to 2.25 ± 0.59 mmol/l (–36.5%; P<0.01), and an increase in high density lipoprotein (HDL) cholesterol from 0.72±0.28 to 0.85±0.34 (+18.1%; NS). Thirteen patients were treated with 40 mg simvastatin per day. Under this regimen there was a further significant decrease in LDL cholesterol from 2.33±0.62 to 1.81±0.49 mmol/l (–22.3%; P<0.01). In six patients who remained hyperlipidemic on monotherapy combination drug therapy with simvastatin (40 mg per day) and gemfibrozil (450 mg per day) was given. Compared to simvastatin alone the addition of gemfibrozil further lowered plasma concentrations of total cholesterol by 14.9%, VLDL cholesterol by 23.5%, and triglycerides by 17.1%, although this was not statistically significant. No patient was discontinued from single or combination drug therapy, and no severe clinical or biochemical side effects were observed. The results of this study demonstrate the usefulness of simvastatin in the therapy of type III HLP and indicate that in individual patients who remain hyperlipidemic on monotherapy combination drug therapy with both of these drugs is effective in further reducing plasma concentrations of total cholesterol, VLDL cholesterol, and triglycerides. Although no patient in this investigation developed myopathy or rhabdomyolysis, combined fibrate-HMG CoA reductase inhibitor treatment should be considered only for severe forms of hyperlipidemia and for patients who do not respond sufficiently to mon-therapy of any of these drugs.Abbreviations Apo
Apolipoprotein
- CPK
creatine phosphokinase
- GGT
gamma-glutamyl transpeptidase
- HDL
high density lipoproteins
- HLP
hyperlipoproteinemia
- HMG CoA
3-hydroxy-3-methyl glutaryl coenzyme A
- IDL
intermediate density lipoproteins
- LDL
low density lipoproteins
- TG
triglycerides
- VLDL
very low density lipoproteins 相似文献
26.
Takada D Emi M Ezura Y Nobe Y Kawamura K Iino Y Katayama Y Xin Y Wu LL Larringa-Shum S Stephenson SH Hunt SC Hopkins PN 《Journal of human genetics》2002,47(12):0656-0664
27.
Olaug K. Rødningen Oddveig Røshy Serena Tonstad Leiv Ose Kåre Berg Trond P. Leren 《Clinical genetics》1992,42(6):288-295
Haplotype analysis of the low density lipoprotein receptor (LDLR) gene was performed in Norwegian subjects heterozygous for familial hypercholesterolemia (FH). Southern blot analysis of genomic DNA, using an exon 18 specific probe and the restriction enzyme NcoI, showed that two out of 57 unrelated FH subjects had an abnormal 3.6 kb band. Further analyses revealed that this abnormal band was due to a 9.6 kb deletion that included exons 16 and 17. The 5' deletion breakpoint was after 245 bp of intron 15, and the 3' deletion breakpoint was in exon 18 after nucleotide 3390 of cDNA. Thus, both the membrane-spanning and cytoplasmatic domains of the receptor had been deleted. A polymerase chain reaction (PCR) method was developed to identify this deletion among other Norwegian FH subjects. As a result of this screening one additional subject was found out of 124 subjects screened. Thus, three out of 181 (1.7%) unrelated Norwegian FH subject possessed this deletion. The deletion was found on the same haplotype in the three unrelated subjects, suggesting a common mutagenic event. The deletion is identical to a deletion (FH-Helsinki) that is very common among Finnish FH subjects. However, it is not yet known whether the mutations evolved separately in the two countries. 相似文献
28.
Barbari A Stephan A Masri M Karam A Aoun S El Nahas J Bou Khalil J 《Molecular immunology》2003,39(17-18):1109-1114
Consanguineous marriages are common in many countries of the Middle East including Lebanon. Their impact on the repartition of kidney diseases and on the risk for familial nephritis is not known. We surveyed all of the dialysis centers in Lebanon. Nine hundred and twenty-five (925) patients and their private physicians were asked to answer a questionnaire. More than half of the hemodialysis (HD) patients had an unknown etiology of their kidney disease. Diabetes, polycystic kidney disease (PKD), chronic pyelonephritis and nephrosclerosis (NS) were the most commonly documented diagnoses. Consanguinity was present in 26% of the total HD population. More consanguineous patients with unknown renal etiology were diagnosed with their kidney diseases and initiated on dialysis before the age of 30 when compared with their non-consanguineous counter-parts (45% versus 33%, P<0.02 and 42% versus 27%, P<0.01), respectively. Similarly, consanguineous polycystic patients were diagnosed and started earlier on dialysis when compared with the non-consanguineous population (34% versus 12%, P<0.05 and 28% versus 8%, P<0.05), respectively suggesting a different disease pattern. Furthermore, the risk for family history of kidney disease was noticeable in the non-consanguineous population and significantly higher among the consanguineous patients (12% versus 18%, P<0.04). Consanguinity-associated kidney diseases affected all religious communities, in particular the Muslim and the Druze (36 and 39%), respectively versus 17% of the Christian community. Certain geographical areas were more involved than others such as the North, South and the Bekaa with the highest percentage (40%) in the latter. Socio-economical level was not a contributing factor. We conclude that the documentation of the underlying etiology in end-stage renal diseases (ESRD) seems to be deficient. Furthermore, consanguinity is prevalent in the Lebanese dialysis patients population, in particular the Muslim and the Druze communities. Consanguinity-associated kidney diseases pattern seems to differ from that of the general HD population by disease diagnosis and initiation at a younger age and a significantly higher risk for familial renal disease. It is a cultural phenomenon prevalent predominantly in the rural areas. We recommend a multi-approach including educational, informative and probably legislative strategy in order to limit and hopefully discourage consanguineous marriages. 相似文献
29.
Tiina Paunio Yoshihide Sunada Sari Kiuru Hideo Makishita Shu-Ichi Ikeda Jean Weissenbach Jorma Palo Leena Peltonen 《Human mutation》1995,6(1):60-65
Familial amyloidosis, Finnish type (FAF) (gelsolin-related amyloidosis) is an autosomal dominant form of systemic amyloidosis characterized by corneal lattice dystrophy and peripheral polyneuropathy. The accumulating protein in FAF consists of fragments of gelsolin, an actin-modulating protein. The gelsolin mutation G654A has been found in both Finnish and Japanese patients. To study the origin of the gelsolin mutation in these patients we performed haplotype analysis in 10 Finnish and 2 Japanese FAF families. Poymorphic DNA markers GSN, D9S103, AFMa061xd9, and AFMa139xb9 revealed a uniform disease haplotype in all the disease-associated chromosomes of the Finnish FAF families, which was different from the one observed in the Japanese families. The present results and the previously detected gelsolin mutation G654T in Czech and Danish FAF patients suggest that nucle otide 654 may represent a mutation hot spot in the gelsolin gene. The DNA markers studied here will be useful in future genealogical analyses of FAF. © 1995 Wiley-Liss, Inc. 相似文献
30.
Sakashita N Ando Y Obayashi K Terazaki H Yamashita T Takei M Kinjo M Takahashi K 《Virchows Archiv : an international journal of pathology》2000,436(4):345-350
We report an autopsy case of a pedigree of familial amyloidotic polyneuropathy (FAP) with a mutation of isoleucine-50 transthyretin
(ATTR Ser50Ile). A 47-year-old man started developing severe diarrhea and weight loss at age 41 years, followed by urinary
incontinence, autonomic-nervous-system abnormalities and serious heart failure; the diagnosis of FAP (ATTR Ser50Ile) was made
on the basis of genetic, histochemical and immunohistochemical analysis. Six years after the initial symptoms, he died of
septic shock. Autopsy revealed suppurative peritonitis, perforation of the sigmoid colon and marked systemic amyloid deposition.
The total amount of amyloid deposited in the heart was greatly increased and was much lower in the thyroid gland and kidneys
compared with amyloid deposits in ordinary FAP (ATTR Val30Met). Amyloid deposition in peripheral vessel walls was prominent,
particularly in lymphatics and veins. His elder sister, 54 years old, started to develop orthostatic hypotension at age 49
years, followed by dysesthesia, diarrhea and severe congestive heart failure. Endomyocardial biopsy revealed severe TTR–amyloid
deposition; ultrastructural examination demonstrated that amyloid fibrils were deposited disproportionately and extended radially
around microvessels. These characteristic patterns of systemic amyloid deposition and distinct clinical manifestations, especially
in the cardiovascular system, are considered to be a characteristic feature of ATTR Ser50Ile amyloidosis.
Received: 31 August 1999 / Accepted: 19 October 1999 相似文献